Stock Analysts

P&G Tops Q4 Earnings on Lower Costs, Lags Sales; Gives View

The Procter & Gamble Company ( PG ) reported mixed fiscal fourth-quarter 2014 results beating the Zacks Consensus Estimate for earnings but missing the same for sales. The consumer products giant met its financial targets for the year and issued a positive outlook for the next fiscal year. Shares rose 1.7% in pre-market trading. […]

Stock Analysts

Live Nation Misses Q2 Earnings on Lower Concert Revenues

California-based concert and entertainment company, Live Nation Entertainment, Inc. ( LYV ) reported mixed second-quarter results wherein earnings missed the Zacks Consensus Estimate, but revenues surpassed the same. Earnings of 11 cents per share missed the Zacks Consensus Estimate of 16 cents by 31.3% […]

Stock Analysts

Clorox Misses on Q4 Earnings, Retains Fiscal 2015 Guidance

The Clorox Company ( CLX ) came up with lower-than-expected financial results for fourth-quarter and fiscal 2014 on account of unfavorable exchange rates in many markets, sluggish product categories and increased competitive activities faced throughout the year. Earnings of $1.30 per share from continuing operations in the fourth quarter missed the Zacks Consensus Estimate of $1.34. […]

Stock Analysts

Nektar’s Loss Narrows in Q2, Beats Revenues, Retains View

Nektar Therapeutics ( NKTR ) reported a loss of 26 cents per share in the second quarter of 2014, narrower than the Zacks Consensus Estimate of a loss of 38 cents and the year-ago loss of 37 cents. Nektar Therapeutics – Earnings Surprise | FindTheBest Total revenues in the reported quarter fell 15.8% year over year to $28.5 million. The decrease in quarterly revenues was primarily due to decreased manufacturing activity […]

Stock Analysts

3 Best Performing Stocks of July

A variety of factors weighed on stocks as benchmarks ended the month with losses. International tensions dominated proceedings, as did comments from the Fed. An observation from Fed Chair Janet Yellen that Internet and biotech stocks may be overvalued sparked off fears among investors. […]

Stock Analysts

Valeant Pharmaceuticals Earnings Up Y/Y, View Lowered

Valeant Pharmaceuticals ’ ( VRX ) reported second quarter 2014 cash earnings per share of $1.91 (excluding special items and non-cash expenses), up from the year-ago earnings of $1.34 per share. Excluding stock-based compensation expense, earnings per share came in at $1.90. The Zacks Consensus Estimate for the second quarter was $1.91. […]

Max Keiser

US corporate rats leave ship for UK

[youtube V7-fGql8vWE] Watch the full Keiser Report Episode 635 on Saturday! In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss the US corporate rats abandoning ship for the United Kingdom where, despite a public health system and higher minimum wage that Fox News claims would destroy America, help keep corporate tax rates, in fact, lower for these formerly American companies wanting to be ruled by the Queen. In the second half, Max interviews comedian Andy Zaltzman, author of “Does anything eat bankers?” about Boris Johnson’s water cannons, Lady Godiva’s role in British history and homeopathic money filling warehouses across London. WATCH all Keiser Report shows here: http://www.youtube.com/playlist?list=PL768A33676917AE90 (E1-E200) http://www.youtube.com/playlist?list=PLC3F29DDAA1BABFCF (E201-E400) http://www.youtube.com/playlist?list=PLPszygYHA9K2ZtV_1KphSugBB7iZqbFyz (E401-600) http://www.youtube.com/playlist?list=PLPszygYHA9K1GpAv3ZKpNFoEvKaY2QFH_ (E601-current) RT LIVE http://rt.com/on-air Subscribe to RT! http://www.youtube.com/subscription_center?add_user=RussiaToday Like us on Facebook http://www.facebook.com/RTnews Follow us on Twitter http://twitter.com/RT_com Follow us on Instagram http://instagram.com/rt Follow us on Google+ http://plus.google.com/+RT RT (Russia Today) is a global news network broadcasting from Moscow and Washington studios […]

Upgrades

APOLLO COMMERCL (ARI) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of APOLLO COMMERCL (ARI) from NEUTRAL to OUTPERFORM on August 01, 2014, with a target price of $17.60. Apollo Commercial Real Estate Finance, Inc. is focused on investing in, acquiring and managing senior performing commercial real estate mortgage loans, commercial mortgage-backed securities, commercial real estate corporate debt and loans, and other real estate debt investments. […]